Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 2.9B | 2.2B | 2.7B | 2.6B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 584M | 479M | 535M | 474M |
Operating income | 178M | 76M | 172M | 145M |
Non operating interest income | ||||
Income | 23M | 20M | 18M | 18M |
Expense | 22M | 23M | 14M | 24M |
Other income expense | — | — | — | — |
Pretax income | 181M | 71M | 176M | 139M |
Tax provision | -23M | 18M | 37M | 36M |
Net income | 203M | 53M | 138M | 103M |
Basic EPS | 0.7 | 0.2 | 0.5 | 0.4 |
Diluted EPS | 0.7 | 0.2 | 0.5 | 0.4 |
Basic average shares | 295.5M | 288.4M | 286.0M | 285.7M |
Diluted average shares | 295.8M | 301.2M | 296.8M | 299.1M |
EBITDA | 332M | 215M | 310M | 283M |
Net income from continuing op. | 181M | 71M | 176M | 139M |
Minority interests | -1M | -2M | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |